EU agency says J&J Covid-19 vaccine's benefits outweigh the risks
AFP, 20 Apr 2021
Europe's medicines regulator says that blood clots should be listed as a very rare side effect of Johnson & Johnson's coronavirus vaccine, but that the benefits of the shot still outweigh the risks. SOUNDBITE
Subscribe to AFP and activate your notifications to get the latest news 🔔
http://www.youtube.com/channel/UC86dbj-lbDks_hZ5gRKL49Q/?sub_confirmation=1